Sprimeo er kontraindikeret under 2. og 3. trimester af graviditeten.
As for any medicine that acts directly on the RAS, Sprimeo should not be used during the first trimester of pregnancy or in women planning to become pregnant and is contraindicated during the second and third trimesters (see section 4.3).